Suven Life Sciences has informed that the details of securities dematerialized/ rematerialized during the quarter ended December 31, 2022, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies, Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies dated January 06, 2023 are enclosed for reference.
The above information is a part of company’s filings submitted to BSE.
